Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Series-B

News 25 million dollars for NatureMetrics New capital for biodiversity innovation: NatureMetrics takes nature reporting to the next level and drives digital solutions for sustainable businesses.

Marc Nemitz 01.01.1970

News Embotech successful with CHF 23.5 million Series B Thanks to new investments, Embotech is driving forward the automation of vehicle and port logistics. With BMW i Ventures as a partner, new solutions are being rolled out worldwide.

Marc Nemitz 28.08.8800

News 26 million US dollars in Series B for AMPECO AMPECO secures fresh capital for global EV charging networks! AMPECO is driving the future of electric mobility with new financing and an innovative platform.

Marc Nemitz 01.01.1970

News The Exploration Company closes 150 million euro Series B round The Exploration Company closes largest Series B round in the European space industry to develop the first European reusable space capsule Nyx and strengthen Europe's sovereignty in space.

Marc Nemitz 01.01.1970

News Bounce secures 19 million US dollars in Series B Bounce receives USD 19 million in Series B funding for the global expansion of its luggage storage network. The startup plans to expand its offering in Germany and other countries.

Marc Nemitz 28.08.8007

News SynOx Therapeutics increases capital to USD 92 million in Series B financing Gilde Healthcare leads Series B extension and supports Phase 3 TANGENT study for emactuzumab, a promising CSF-1R-targeted therapy for tenosynovial giant cell tumor

Marc Nemitz 01.01.1970

News Aignostics secures 34 million US dollars in Series B Aignostics strengthens precision medicine through AI-based pathology models. The funds will be used for new products, US expansion and collaboration with the Mayo Clinic.

Marc Nemitz 01.01.1970

News AvenCell secures USD 112 million in Series B funding AvenCell plans to use USD 112 million in funding to further develop its switchable CAR-T cell therapy platform. The goal: safer and more flexible treatments for cancer and autoimmune diseases.

Marc Nemitz 01.01.1970

News osapiens receives 120 million US dollars in financing round With the support of Goldman Sachs Alternatives, osapiens aims to facilitate compliance with international ESG regulations and further develop its technology platform.

Marc Nemitz 01.01.1970

News Prewave raises 67 million US dollars Prewave raises 67 million US dollars to help companies manage supply chain risks. Customers such as Toyota and Ferrari are already using the Vienna-based start-up's AI-supported platform.

Marc Nemitz 01.01.1970

1
2
3
4